Search - tctmd.com

Displaying 101 - 120 of 610

Sort: Relevancy | Date

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Daily News

Statins Started in Kids With FH Provide Benefits in Adulthood

Yael L. Maxwell

October 17, 2019

News Daily News

CMS Cuts to Office-Based Noninvasive Cardiac Tests Are Driving Costs Higher

L.A. McKeown

October 17, 2019

News Daily News

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

Yael L. Maxwell

October 16, 2019

News Opinion Off Script TCT 2019

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

Kwan S. Lee

October 14, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Caitlin E. Cox

October 10, 2019

News Daily News

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

L.A. McKeown

October 09, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

L.A. McKeown

October 09, 2019

News Conference News TCT 2019

Pacemaker-Based Approach Tricks the Body Into Lower BP: MODERATO II

Todd Neale

October 09, 2019

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

News Conference News TCT 2019

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

Yael L. Maxwell

October 08, 2019

News Conference News

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Michael O'Riordan

October 07, 2019

News Daily News

Interventional Options and Future Directions for Acute PE: New AHA Statement

Todd Neale

October 07, 2019

News Conference News TCT 2019

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

Caitlin E. Cox

October 04, 2019

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Todd Neale

October 04, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Conference News TCT 2019

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Caitlin E. Cox

October 01, 2019

Off Script: A (Not So) Brief History of Aspirin’s Rise and Fall

News Opinion Off Script TCT 2019

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Kwan S. Lee

September 29, 2019

Advertisement

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Statins Started in Kids With FH Provide Benefits in Adulthood

CMS Cuts to Office-Based Noninvasive Cardiac Tests Are Driving Costs Higher

Ticagrelor Monotherapy After Multivessel PCI? Latest Slice From GLOBAL LEADERS Says . . . Maybe

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

Recurrent Events Common Among Young Patients With CAD

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

Pacemaker-Based Approach Tricks the Body Into Lower BP: MODERATO II

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials

Interventional Options and Future Directions for Acute PE: New AHA Statement

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR

Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content